Skipping the two-step? Possible mechanisms of Epstein–Barr virus reactivation

[1]  L. Bonaldi,et al.  Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein–Barr virus reactivation , 2003, Leukemia.

[2]  P. Dennis,et al.  The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease. , 2002, Frontiers in bioscience : a journal and virtual library.

[3]  D. Thorley-Lawson,et al.  EBV Persistence Involves Strict Selection of Latently Infected B Cells1 , 2000, The Journal of Immunology.

[4]  M. Cannon,et al.  Functional Analysis of the CD4+ T-Cell Response to Epstein-Barr Virus: T-Cell-Mediated Activation of Resting B Cells and Induction of Viral BZLF1 Expression , 2000, Journal of Virology.

[5]  R. Freeman,et al.  Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients , 1999, The Journal of experimental medicine.

[6]  D. Thorley-Lawson,et al.  EBV persistence in memory B cells in vivo. , 1998, Immunity.

[7]  A. Rickinson,et al.  Cytotoxic T lymphocyte responses to Epstein-Barr virus. , 1996, Current opinion in immunology.

[8]  Nalesnik Ma.  Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. , 1996, Seminars in thoracic and cardiovascular surgery.

[9]  G. Winberg,et al.  A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 , 1995, Journal of virology.

[10]  D. Mosier,et al.  Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes , 1995, Journal of virology.

[11]  L. Young,et al.  Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state , 1994, Journal of virology.

[12]  A. Del Mistro,et al.  Lymphoproliferative disease in human peripheral blood mononuclear cell- injected SCID mice. I. T lymphocyte requirement for B cell tumor generation , 1992, The Journal of experimental medicine.

[13]  K. Berend,et al.  Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus. , 1992, Surgery.

[14]  D. Rowe,et al.  Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes , 1992, Journal of virology.

[15]  B. Katz,et al.  Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders. , 1992, The American journal of pathology.

[16]  H. Lyerly,et al.  Effects of cyclosporine on human B-cell lymphoma development in vivo. , 1992, Surgical oncology.

[17]  A. Rickinson,et al.  Spontaneous outgrowth of epstein‐barr virus‐positive B‐cell lines from circulating human B cells of different buoyant densities , 1991, International journal of cancer.

[18]  L. Young,et al.  Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man , 1991, The Journal of experimental medicine.

[19]  N. Cooper,et al.  Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. , 1990, The Journal of clinical investigation.

[20]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[21]  N. Raab-Traub,et al.  Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. , 1989, The Journal of infectious diseases.

[22]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[23]  R. Simmons,et al.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. , 1985, Transplantation.

[24]  M. Epstein,et al.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. , 1984, Cellular immunology.

[25]  M. Epstein,et al.  EPSTEIN-BARR-VIRUS-SPECIFIC T-CELL MEMORY IN RENAL-ALLOGRAFT RECIPIENTS UNDER LONG-TERM IMMUNOSUPPRESSION , 1982, The Lancet.

[26]  J. H. Pope,et al.  Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. IV. Development of T‐cell memory in convalescent infectious mononucleosis patients , 1980, International journal of cancer.

[27]  M. Epstein,et al.  Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: Origin of transformed cells arising in co‐cultures with foetal lymphocytes , 1977, International journal of cancer.

[28]  M. Epstein,et al.  Observations on the type of infection by epstein‐barr virus in peripheral lymphoid cells of patients with infectious mononucleosis , 1974, International journal of cancer.

[29]  J. Sebus,et al.  POTASSIUM DEPLETION AND CHRONIC PYELONEPHRITIS. , 1964, Lancet.

[30]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[31]  M. Allday,et al.  Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. , 1991, Advances in cancer research.